Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ST. PAUL, Minn., Nov. 10, 2015 (GLOBE NEWSWIRE) -- GovDelivery, the leading provider of cloud-based solutions enhancing the citizen experience, today announced that government is now reaching over 100...
-
PLAYA DEL CARMEN, Mexico, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Mahekal Beach Resort announces the final phase of its three-year, $16 million dollar re-imagination - which first began in September 2013...
-
MCLEAN, VA., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Today, Vricon releases a medium-resolution global digital surface model (DSM) for $1.99 per km2 that defines a new industry standard for this product...
-
BOISE, Idaho, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Micron Technology, Inc., (Nasdaq:MU) announces the production of 8GB DDR4 NVDIMM, the company's first commercially available solution in the persistent...
-
MINNEAPOLIS, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (NASDAQ:SKLNU) announced today that as part of its international expansion strategy the Company is in the process...
-
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...
-
REDWOOD CITY, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Ynext, the division of Yodlee, Inc. (NASDAQ:YDLE) that incubates, delivers and commercializes new business opportunities for the company, today...
-
DELRAY BEACH, Fla., Nov. 10, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company with an extensive patent portfolio, announced today...
-
NEW YORK, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder...
-
NEWARK, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet...